Agile Therapeutics shares were on the rise this week, rocketing nearly 300% after the women’s healthcare company said a U.S. Food and Drug Administration advisory committee voted in favor of its contraceptive patch Twirla. The FDA’s Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) met to discuss Agile’s New Drug Application (NDA) for Twirla, the … Continue reading “Agile Therapeutics Shares Explode as Contraceptive Patch Twirla Gets Nod from FDA”
Biotech & Pharma
Biotech & Pharma
Biogen Surprises Wall Street With This News
Biogen announced on Tuesday that its Alzheimer's treatment was ready to start the regulatory approval…
October 23, 2019
Biotech & Pharma
Reata Pharmaceuticals Explodes as Company Meets Study Endpoint
Shares of Reata Pharmaceuticals were popping on Monday in after-hours trading as Wall Street learned…
October 15, 2019
Biotech & Pharma
Akcea Therapeutics Soars on Licensing Agreement with Pfizer
Shares of Akcea Therapeutics were exploding on Monday after the company revealed that it had…
October 8, 2019
Biotech & Pharma
Drugstores Are Suspending Sales of Heartburn Medicine Zantac Due to This Health Concern
Walgreens just became the latest retailer to suspend sales of Zantac, a heartburn medicine from…
October 1, 2019
Biotech & Pharma
Tocagen Inc. Falls Over 80% After Late-stage Trial Fails to Meet Endpoint
Shares of Tocagen Inc. were plummeting on Thursday, falling over 80% to a new record…
September 13, 2019
Biotech & Pharma
Sarepta Therapeutics Shares Collapse on Serious Duchenne Gene Therapy Complication
Shares of Sarepta Therapeutics fell as much as 13% on Thursday after Wall Street learned…
August 9, 2019
Biotech & Pharma
Acadia Pharmaceuticals Takes a Nose Dive After Schizophrenia Drug Fails
Acadia Pharmaceuticals Inc. shares were on a decline in after-hours trading on Monday as Wall…
July 22, 2019
Biotech & Pharma
The FDA Has Granted Prevail’s Parkinson’s Treatment Fast Track Designation
Prevail Therapeutics shares were on the rise on Monday after Wall Street learned that the…
July 9, 2019
Biotech & Pharma
Dangerous Side Effects Prompts FDA to Suspend Unum Therapeutics’ Cancer Drug Trial
Shares of Unum Therapeutics were on a downward turn this week after the Food and…
July 5, 2019
Biotech & Pharma
Pfizer to Buy Array BioPharma for $11.4 Billion
Pharmaceutical giant Pfizer revealed this week that it is going to acquire Array BioPharma in…
June 17, 2019
Biotech & Pharma
Merck to Buy Tilos Therapeutics for up to $773 Million
Merck announced this week that it has reached an agreement to buy privately held biopharmaceutical…
June 10, 2019
Biotech & Pharma
Novartis’ Gene Therapy Gets Nod from FDA
Shares of Novartis were climbing higher on Friday after the Food and Drug Administration (FDA)…
May 25, 2019
Biotech & Pharma
Merck & Co Inc. Agrees to Buy Peloton Therapeutics
In a $1.05 billion transaction, Merck & Co Inc. has announced this week that it…
May 22, 2019